annual ROE:
-37.45%+19.35%(+34.07%)Summary
- As of today (September 19, 2025), VRDN annual return on equity is -37.45%, with the most recent change of +19.35% (+34.07%) on December 31, 2024.
- During the last 3 years, VRDN annual ROE has risen by +14.16% (+27.44%).
- VRDN annual ROE is now -242.94% below its all-time high of 26.20%, reached on December 31, 2012.
Performance
VRDN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-54.32%-6.95%(-14.67%)Summary
- As of today (September 19, 2025), VRDN quarterly return on equity is -54.32%, with the most recent change of -6.95% (-14.67%) on June 30, 2025.
- Over the past year, VRDN quarterly ROE has dropped by -1.37% (-2.59%).
- VRDN quarterly ROE is now -127.87% below its all-time high of 194.93%, reached on September 30, 2014.
Performance
VRDN quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VRDN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.1% | -2.6% |
| 3 y3 years | +27.4% | +11.5% |
| 5 y5 years | +70.0% | +63.5% |
VRDN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.1% | -25.0% | +18.3% |
| 5 y | 5-year | at high | +77.0% | -25.0% | +79.9% |
| alltime | all time | -242.9% | +77.0% | -127.9% | +79.9% |
VRDN ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -54.32%(+14.7%) |
| Mar 2025 | - | -47.37%(+9.0%) |
| Dec 2024 | -37.45%(-34.1%) | -43.45%(-14.0%) |
| Sep 2024 | - | -50.51%(-4.6%) |
| Jun 2024 | - | -52.95%(-4.1%) |
| Mar 2024 | - | -55.23%(-17.0%) |
| Dec 2023 | -56.80%(+27.4%) | -66.52%(+7.7%) |
| Sep 2023 | - | -61.76%(+0.6%) |
| Jun 2023 | - | -61.37%(+4.2%) |
| Mar 2023 | - | -58.89%(+17.9%) |
| Dec 2022 | -44.57%(-13.6%) | -49.94%(-1.9%) |
| Sep 2022 | - | -50.92%(-17.0%) |
| Jun 2022 | - | -61.38%(+8.2%) |
| Mar 2022 | - | -56.72%(+2.5%) |
| Dec 2021 | -51.61%(-68.4%) | -55.36%(-56.8%) |
| Sep 2021 | - | -128.24%(-29.0%) |
| Jun 2021 | - | -180.66%(-11.9%) |
| Mar 2021 | - | -205.13%(-24.0%) |
| Dec 2020 | -163.07%(+30.7%) | -270.03%(+94.1%) |
| Sep 2020 | - | -139.14%(-6.4%) |
| Jun 2020 | - | -148.62%(+8.9%) |
| Mar 2020 | - | -136.43%(+7.3%) |
| Dec 2019 | -124.81% | -127.15%(+26.7%) |
| Sep 2019 | - | -100.35%(+28.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | -78.41%(+16.0%) |
| Mar 2019 | - | -67.61%(+20.3%) |
| Dec 2018 | -72.79%(-26.5%) | -56.20%(+8.8%) |
| Sep 2018 | - | -51.64%(+4.6%) |
| Jun 2018 | - | -49.37%(-2.2%) |
| Mar 2018 | - | -50.50%(-30.7%) |
| Dec 2017 | -99.01%(-27.2%) | -72.90%(-17.3%) |
| Sep 2017 | - | -88.20%(-16.7%) |
| Jun 2017 | - | -105.83%(-11.1%) |
| Mar 2017 | - | -119.04%(-30.6%) |
| Dec 2016 | -136.05%(-1.5%) | -171.58%(+17.5%) |
| Sep 2016 | - | -145.99%(+24.9%) |
| Jun 2016 | - | -116.86%(+13.2%) |
| Mar 2016 | - | -103.22%(-3.2%) |
| Dec 2015 | -138.14%(+4.9%) | -106.61%(+1.0%) |
| Sep 2015 | - | -105.54%(+7.0%) |
| Jun 2015 | - | -98.66%(-11.7%) |
| Mar 2015 | - | -111.78%(+14.0%) |
| Dec 2014 | -131.70%(-1556.9%) | -98.04%(-150.3%) |
| Sep 2014 | - | 194.93%(+256.5%) |
| Jun 2014 | - | 54.68%(+1309.3%) |
| Dec 2013 | 9.04%(-65.5%) | 3.88%(-41.9%) |
| Sep 2013 | - | 6.68%(-49.4%) |
| Dec 2012 | 26.20% | - |
| Dec 2012 | - | 13.21% |
FAQ
- What is Viridian Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual ROE year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly ROE year-on-year change?
What is Viridian Therapeutics, Inc. annual return on equity?
The current annual ROE of VRDN is -37.45%
What is the all time high annual ROE for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual return on equity is 26.20%
What is Viridian Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, VRDN annual return on equity has changed by +19.35% (+34.07%)
What is Viridian Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of VRDN is -54.32%
What is the all time high quarterly ROE for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly return on equity is 194.93%
What is Viridian Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, VRDN quarterly return on equity has changed by -1.37% (-2.59%)